Newfund HEKA

About Newfund HEKA

Europe's first BrainTech VC fund at €60M, engineered as a transatlantic bridge. Invests in neuroscience, brain-computer interfaces, and neurotech startups at seed stage.

Investment Focus

Location / RegionFrance

Funding StageSeed

Industry Focus

Biotech

Deep Tech

Investor Signals Profile

active

Sweet Spot

European neurotech founder needing science-literate seed + US bridge

BrainTech

Neuro-AI

Digital Therapeutics

Medical Imaging

CNS Biotech

Bullish Signals

€60M closed, 9 deals pre-closeblog

900+ screened, 1% hit rateblog

Active Palo Alto office, 50 US portfolio cosblog

Europe's only dedicated BrainTech fundblog

BFM TV media coverage, BrainTech narrativetwitter

$4.2B raised globally in BrainTech startupstwitter

fUSI & fNIRS foundation models on radartwitter

Contrarian Signals

Digital therapeutics public market brutalblog

Series B gap still painful in Europeblog

Exit path: US acquirers, not IPOsblog

European VC seed funding down 66%twitter

Founder Do's

Lead with data, papers, clinical endpoints

Have clear regulatory pathway mapped

Strong neuroscience research foundation

Need transatlantic commercialization support

Pre-seed or seed stage, €250K–€2M range

Founder Don'ts

No brain-adjacent branding without real science

No generic wellness or productivity apps

Don't lead with TAM slides

Key GPs & Partners

François Véron

Managing Partner

thesis-drivenex-foundermedia-active

Anne-Sophie Saint-Martin

Partner

thesis-drivenhands-on

Henri Deshays

Partner

hands-oncommunity-builder

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€60M

Saves0

Website

Key People

François Véron

François VéronManaging Partner

Anne-Sophie Saint-MartinPartner

Henri DeshaysPartner